Skip to main content
OpenTrials
Completed

NCT Number: NCT02528058

Ultrastructure Analysis of Excised Internal Limiting Membrane in Eyes of Highly Myopia With Myopic Traction Maculopathy

The excised ILM from 7 eyes of 7 patients with MTM including 7 eyes with macular retinoschisis and 4 eyes with foveal detachment but without any retinal break underwent vitrectomy with induction of posterior vitreous detachment and ILM peeling was examined to evaluate ultrastructure with electron microscopy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Makoto Inoue

Mitaka, Tokyo, 181-8611, Japan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The inclusion criteria were patients who underwent vitrectomy and internal limiting membrane peeling for myopic traction maculopathy and had a follow-up for more than 6 months.

Exclusion criteria

  • The patients with follow-up less than 6 months

Treatment and study plan

Vitrectomy with internal limiting membrane peeling

Procedure

Primary outcomes

  1. Visual acuity before and after surgery

    Time frame: 6 months

    Comparison in logarithm of Minimum Angle of Resolution (logMAR) vision

Secondary outcomes

  1. Retinal reattachment

    Time frame: 6 months

    Resolution of macular retinoschisis and foveal detachment

Sponsors and collaborators

Lead sponsor

Kyorin University

Other

Registry information

Important dates

Study start
2010
Primary completion
2014
Study completion
2015
First posted
Aug 19, 2015
Registry last updated
Aug 19, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.